0 — Class II drug recall D-0861-2016
Terminated recall by Baxter Healthcare Corp., reported 2016-06-01, distributed nationwide. Lack of Assurance of Sterility: potential for leaking containers which lacks the assurance of sterility.
| Recall number | D-0861-2016 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Baxter Healthcare Corp., Deerfield, IL, United States |
| Recall initiated | 2016-01-21 |
| Classified | 2016-05-23 |
| Reported by FDA | 2016-06-01 |
| Terminated | 2018-02-26 |
| Distributed | Nationwide (US) |
| Quantity | 282,080 bags |
| Reason classes | sterility, packaging |
| NDC | 00338-0553, 00338-0553-11, 00338-0553-18 |
| Lot numbers | P337857 |
| Expiration dates | 2016-07-31 |
Product
0.9% Sodium Chloride Injection USP, MINI-BAG Plus Container, 100 mL VIAFLEX Single Dose Container bags, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015, Product Code 2B0043, NDC 0338-0553-18.
Reason for recall
Lack of Assurance of Sterility: potential for leaking containers which lacks the assurance of sterility.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0861-2016. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.